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Abstract: Peripheral immune regulation is critical for the maintenance of self-tolerance. Here we
have investigated signaling processes that distinguish T cells with regulatory capability from effector
T cells. The murine Tg4 T cell receptor recognizes a peptide derived from the self-antigen myelin
basic protein. T cells from Tg4 T cell receptor transgenic mice can be used to generate effector T cells
and three types of T cells with regulatory capability, inducible regulatory T cells, T cells tolerized by
repeated in vivo antigenic peptide exposure or T cells treated with the tolerogenic drug UCB9608
(a phosphatidylinositol 4 kinase IIIβ inhibitor). We comparatively studied signaling in all of these
T cells by activating them with the same antigen presenting cells presenting the same myelin basic
protein peptide. Supramolecular signaling structures, as efficiently detected by large-scale live cell
imaging, are critical mediators of T cell activation. The formation of a supramolecular signaling
complex anchored by the adaptor protein linker for activation of T cells (LAT) was consistently
terminated more rapidly in Tg4 T cells with regulatory capability. Such termination could be partially
reversed by blocking the inhibitory receptors CTLA-4 and PD-1. Our work suggests that attenuation
of proximal signaling may favor regulatory over effector function in T cells.
Keywords: regulatory T cell; tolerance; immunological synapse; central supramolecular activation
cluster (cSMAC); supramolecular signaling complex; linker for activation of T cells (LAT); inhibitory
receptors; CTLA-4; PD-1
1. Introduction
The random combinatorial generation of adaptive immune receptors by somatic
recombination leads to emergence of substantial numbers of self-reactive B and T cells
with a range of receptor affinities to self. While strongly self-reactive cells are eliminated
by negative selection, the activation of adaptive immune cells with lower affinities for
self needs to be suppressed by peripheral tolerance mechanisms to prevent autoimmune
disease. Regulatory T cells (Treg) as defined by the transcription factor FoxP3 are a key
element of peripheral tolerance [1]. They are generated during T cell development in
the thymus through high affinity engagement of the TCR just below the threshold of
negative selection as thymic Tregs [2,3] or upon activation of naïve T cells as enhanced
by the cytokines TGFβ and IL-2 as peripheral Tregs [4,5]. Peripheral Treg generation can
be recapitulated in vitro through activation of naïve T cells in the presence of TGFβ and
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high concentrations of IL-2 in the absence of other lineage-defining cytokines, leading to
inducible Tregs (iTreg) [6]. All forms of Tregs are potent suppressors of autoimmune disease
through a variety of mechanisms. The inhibitory receptor CTLA-4 is highly expressed by
Tregs and can contribute to immune regulation [7,8], for example by stripping migratory
dendritic cells of the costimulatory ligands CD80 and CD86 [9].
As an additional mechanism of peripheral immune regulation, repeated exposure of
T cells to antigen can divert activated T cells to a regulatory phenotype, Tr1-like, character-
ized by secretion of IL-10 [10]. This can be applied therapeutically by injecting self peptides
under non-immunogenic conditions in an escalating dose response [11,12]. Again, T cells
therapeutically tolerized are characterized by high expression of inhibitory receptors [11].
In addition to strategies to promote in vitro or in vivo induction of regulatory and tolerized
T cells to suppress unwanted immune responses, pharmacological treatments which foster
induction of T cell tolerance are being explored. A potent inhibitor of the human mixed
lymphocyte reaction targeting phosphatidylinositol 4-kinase IIIβ, UCB9608, can prevent
the rejection of heterotopic allogeneic heart transplants in mice [13,14], establishing it as a
pharmacological inducer of T cell tolerance. For a comparative understanding of signaling
in different elements of T cell tolerance, we here investigate activation of iTregs, in vivo
tolerized T cells and T cells treated with UCB9608.
In T cell activation, antigen specificity is mediated by recognition of peptide/MHC
complexes on the surface of an antigen presenting cell (APC) by the T cell receptor (TCR).
A common theme in T cell tolerance is that the same TCR can support immunity and
tolerance, be it in the differentiation of naïve T cells into T effector versus regulatory T cells,
in changing T cell function from immunity to tolerance upon repeated TCR engagement
with antigen or in drug treatment to switch T cell function from immunity to tolerance. This
raises two questions that we address here. What are signaling differences between immuno-
genic and tolerogenic T cells? Are there conserved signaling phenotypes in different types
of T cells with regulatory capability? Signaling can be assessed at various levels. Commonly
used are the posttranslational modification of signaling intermediates, such as their phos-
phorylation, or changes in gene expression. A particularly sensitive means to investigate
signaling is the single cell determination of the formation and composition of supramolec-
ular signaling structures in the activation of live T cells [15]. T cell signaling controls and is
controlled by large subcellular structures: Prominent are F-actin based structures such as
a peripheral F-actin ring to stabilize the interface with APCs [16,17] or an F-actin-based
lamella to stabilize proximal signaling complexes [18]. Signaling intermediates can be
segregated at the T cell distal pole [19] and brought together in supramolecular protein
complexes, prominently at the center of the T cell/APC interface [20]. A supramolecular
protein complex at the center of the T cell/APC interface, the central supramolecular
activation cluster (cSMAC), is of particular interest as it is dynamically enriched in many
proximal signaling intermediates [21]. Its formation is required during the first two minutes
of T cell activation for efficient generation of IL-2 [15]. It is antagonized by a transient
µm scale invagination to remove proximal signaling intermediates from the cellular in-
terface [22]. Common for all of these structures is that they can be readily detected by
large-scale live cell imaging as a function of time in single T cells activated by APCs and
that their formation is highly sensitive to changes in T cell activation conditions [15,21]. A
parallel determination of the dynamic formation of supramolecular signaling structures
thus provides a sensitive fingerprint of T cell signaling.
Various types of tolerized or regulatory T cells display defects in signaling and its
spatiotemporal organization. This is not surprising given the prominent expression of
inhibitory receptors on such cells [7,11,23,24]. Tregs have a broadly dampened proximal
signaling network [25]. T cells that continuously encounter their antigen in vivo display
attenuated calcium signaling. Nevertheless, their transcriptional profile is more similar
to that of effector T cells than that of Tregs [26]. Various aspects of T cell organization
are impaired in tolerized or regulatory T cells [27–32]. What is missing is a study where
signaling in various types of T cells with regulatory capability is directly compared. Here
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we use the Tg4 TCR transgenic system [33] to generate effector T cells, iTregs, in vivo
tolerized T cells and T cells tolerized by treatment with the phosphatidylinositol 4-kinase
IIIβ inhibitor UCB9608 [13]. Because all types of T cells in our experiments express the
same Tg4 TCR, we can activate the T cells with the same APCs presenting the same peptide
at the same concentration. Resulting changes in T cell activation are then not governed by
different modalities of TCR engagement but are the consequence of different functional
states. The formation of a supramolecular protein complex at the center of the T cell/APC
interface was consistently less stable in the various forms of Tg4 T cells with regulatory
capability. Stabilization of this complex with synthetic approaches or by blocking inhibitory
receptors enhanced T cell function.
2. Materials and Methods
2.1. Mice
Tg4 [33] mice were bred in-house and maintained under SPF conditions with ad libi-
tum access to water and standard chow at the University of Bristol. All animal experiments
were carried out under the UK Home Office Project Licence number 30/2705 held by David
C. Wraith and the study was approved by the University of Bristol Animal Welfare and
Ethical Review Body. For immunotherapeutic tolerance induction, mice were treated s.c.
every 3–4 days with 200µL of MBP Ac1-9[4Y] in phosphate-buffered saline (PBS) in a dose
escalation regime from 0.08 µg to 80 µg peptide in 4 treatments of 10-fold increases in
peptide amount per treatment followed by two more treatments at the highest dose [11].
2.2. T Cell Culture
T cell cultures were set up from spleen or lymph node suspensions from Tg4 mice
that had undergone in vivo tolerance induction (Ttol) or were left untreated (all other
types of T cells). To generate Teff pep or Ttol cells, 4–5 × 106 splenocytes or lymphocytes
were incubated with 10 µg/mL MBP Ac1-9[4K]. Recombinant human IL-2 (TECIN, NCI
Biological Resource Branch, Frederick, MD, USA) was added 24 h later at 50 U/mL.
To generate iTreg pep cells, 4–5 × 106 splenocytes or lymphocytes were incubated with
10 µg/mL MBP Ac1-9[4K] in the presence of 10 ng/mL TGFβ (Peprotech, London, UK) and
100 U/mL rhIL-2. Naïve T cells are commonly primed with antibodies instead of agonist
peptide. To generate such T ab cells, CD4+ Tg4 T cells were purified from Tg4 splenocytes or
lymphocytes with the MagniSort Mouse CD4 T cell Enrichment Kit (eBioscience, San Diego,
CA, USA) according to the MagniSort Negative Selection Protocol III. Naïve CD4+ T cells
were cultured in a 48-well plate (1.5 × 106 per well) coated with 1 µg/mL anti-CD3ε clone
145-2C11 (eBioscience) and 2 µg/mL anti-CD28 clone 37.51 (eBioscience) for 48 h and then
transferred to antibody-free wells. To generate Teff ab T cells, rhIL-2 was added at 24 h at
50 U/mL. iTreg ab T cells were cultured in the presence of 10 ng/mL TGFβ and 100 U/mL
rhIL-2. T cells were used at 5–6 days of culture. To determine roles of inhibitory receptors
in iTreg generation, the inhibitory receptors CTLA-4 and PD-1 were blocked for the entire
duration of the iTreg culture with 10 µg/mL each of anti-CTLA-4 (clone 9D9, provided by
AstraZeneca) and anti-PD-1 (clone RMP1-14, provided by AstraZeneca) antibodies.
2.3. Cell Lines
PL8 cells [34] are a B cell hybridoma expressing I-Au MHC at high to intermediate
levels. They were maintained in culture in RPMI with 10% FBS.
2.4. Flow Cytometry, Proliferation and Cytokine Measurement
For intracellular staining for Foxp3, the Foxp3/Transcription Factor Staining Buffer Set
(eBioscience, San Diego, CA, USA) was used. Cells were fixed in Fixation/ Permeabilization
reagent on ice for at least 30 min and then washed twice with Permeabilization buffer. Cells
were resuspended in Permeabilization buffer and stained with anti-Fopx3 clone FJK-16s
(1 µg/mL, eBioscience, San Diego, CA, USA) on ice for 30 min, washed and analyzed. For
cell surface and intracellular staining of Teff pep and Ttol cells, cells were activated for 4 h
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at 37 ◦C with PMA and ionomycin at 5 ng/mL and 500 ng/mL, respectively, upon addition
of Golgi Stop (BD Biosciences, San Jose, CA, USA) diluted to a final concentration of
1:1500. Cells were washed in ice cold PBS and stained with Fixable Viability Dye eFluor780
(eBioscience, San Diego, CA, USA) at 1 µL/mL in PBS for 20 min at room temperature.
Cells were washed in PBS with 2 mM EDTA and 2% FBS and incubated with anti-mouse
CD16/32 Fc block (eBioscience, San Diego, CA, USA) at 4 µg/mL for 5 min at room
temperature. For extracellular staining, cells were incubated with fluorophore-conjugated
antibodies, anti-LAG3 clone C9B7W (2 µg/mL) and anti-PD1 clone RPM1-30 (1 µg/mL,
BioLegend, San Diego, CA, USA), for 30 min at 4 ◦C. For intracellular cytokine staining,
cells were incubated with IC Fixation Buffer (eBioscience, San Diego, CA, USA) for 30 min
at 4 ◦C, washed twice with Permeabilization Buffer (eBioscience, San Diego, CA, USA)
and incubated with anti-IFNγ clone XMG1.2 (1 µg/mL, BD Biosciences, San Diego, CA,
USA) or anti-IL-10 clone JES5-16E3 (1 µg/mL, BioLegend, San Diego, CA, USA) diluted
into Permeabilization Buffer for 30 min at 4 ◦C, washed and analyzed.
For in vitro intracellular dye dilution proliferation assays, splenic CD4+ T cells were
isolated from untreated Tg4 mice using a CD4+ T-cell isolation kit (Miltenyi Biotec, Bergisch
Gladbach, Germany) and labelled with 5µM CellTrace Violet (CTV) (Invitrogen Carlsbad,
CA, USA). CTV-labelled responder CD4+ T cells (5 × 105) were then cultured with 1 × 106
irradiated B10.PL splenocytes as APC and 0.1 to 10µg mL−1 MBP Ac1-9[4K]. CTV dilution
was determined by flow cytometry on day 4.
To determine concentrations of IFNγ and IL-10 in tissue culture supernatants, super-
natants were collected from cell culture by centrifugation and stored at −20 ◦C or used on
the day. The OptEIA ELSIA kits from BD Biosciences (San Diego, CA, USA) were used
according to the manufacturer’s protocol. Briefly, Nunc-Immuno MicroWell 96-Well Plates
(Thermofisher, Waltham, MA, USA) were coated with 100 µL capture antibody diluted in
coating buffer at 4 ◦C overnight. Wells were blocked with >200 µL assay diluent for 1 h at
room temperature. 100 µL sample was incubated at room temperature for 2 h. Detection
antibody and enzyme reagent were incubated for 1 h at room temperature. Duplicates or
triplicates were applied.
2.5. Retroviral Transduction
Retroviral vectors for the expression of LAT-GFP, the DAG sensor (C1)2-GFP, TCRζ-
GFP, the F-actin sensor F-tractin-GFP, LAT V3-GFP, and LAT Vav-GFP have been pub-
lished [15,18]. Generation of MMLV-based recombinant retrovirus, retroviral infection of
primary T cells at 48 h of culture and FACS sorting for sensor-GFP+ T cells at minimal
sensor expression levels as close as possible to endogenous protein levels at day 5 of culture
have been described in detail [21,35,36].
2.6. Live Cell Imaging
Live cell imaging of Tg4 T cells has been described in detail [36]. Briefly, PL8 cells
were pre-loaded with 10 µg/mL MBP Ac1-9 [4Y] peptide for >4 h and combined with
pre-sorted GFP+ T cells in a glass-bottom plate on the stage of a spinning disk microscope
system (UltraVIEW 6FE system, Perkin Elmer, Waltham, MA, USA; DMI6000 microscope,
Leica, Wetzlar, Germany; CSU22 spinning disk, Yokogawa, Tokyo, Japan). GFP data was
collected as 21 z-sections at 1 µm intervals every 20 s at 37 ◦C in PBS containing 10% FCS, 1
mM CaCl2 and 0.5 mM MgCl2. To determine roles of inhibitory receptors, the inhibitory
receptors CTLA-4 and PD-1 were blocked with 10 µg/mL each of anti-CTLA-4 (clone
9D9, provided by AstraZeneca) and anti-PD-1 (clone RMP1-14, provided by AstraZeneca)
antibodies.
Images were analyzed with the Metamorph software (Molecular Devices, San Jose,
CA, USA). Cell couples were identified using the differential interference contrast (DIC)
bright field images as when either the T cell/APC interface had reached its full width or the
cells had been in contact for 40 s, whichever came first. The subcellular localization of GFP-
tagged protein sensors at each time point was classified. Interface enrichment of fluorescent
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proteins at less than 35% of the cellular background was classified as no accumulation. For
enrichment above 35% six mutually exclusive interface patterns that reflect supramolecular
subcellular structures were: accumulation in a large supramolecular protein complex at
the center of the T cell:APC interface [15,21] (central), accumulation in a large presumably
degradative T cell invagination [22] (invagination), accumulation that covered the cell
cortex across central and peripheral regions (diffuse), accumulation in a broad actin-based
interface lamella [18] (lamellal), accumulation at an F-actin ring at the periphery of the
interface (peripheral) or in smaller membrane protrusions (asymmetric). Geometrical
criteria for pattern classification are detailed in [21] and patterns are graphically illustrated
in Supplementary Figure S2A.
For corroboration, some imaging data were also analyzed using computational meth-
ods [35,37,38] incorporated into CellOrganizer v2.8.1 (http://www.cellorganizer.org).
Briefly, starting with the manual cell couple identification described above T cells were
segmented, reoriented with the T cell:APC interface facing up using the most recent im-
plementation of the one point method [38] and the cell shape was standardized to a half
spheroid to allow voxel-by-voxel comparison across all cell couples analyzed. To mea-
sure interface enrichment, we defined an interface enrichment region as the 10% most
fluorescent voxels of the average probability distribution across all cells and time points.
We defined enrichment to be the ratio of the mean probability in the distribution of that
sensor for that cell at that time point within the interface enrichment region and the mean
probability in the entire cell. To measure enrichment at the interface center, we defined a
small cylindrical “central core” region reaching from the interface center into the T cell:
with the relative radius of the interface set to be “1” we used a relative radius and height
(depth into the cell) of the central cylinder of “0.5”.
For the morphometric analysis we drew up to four lines in DIC images of T cell/APC
couples at defined times relative to tight cell couple formation. The “interface diameter”
connects the two outmost points at each edge of the interface. The “cell width” is a line at
the widest part of the T cells perpendicular to a line connecting the center of the interface
with its posterior end (see cell length). We used a combination of two criteria to determine
whether a T cell has a scorable lamella, the existence of a “neck”, i.e., a point between the
interface and the widest part of the cell where the cell diameter is smaller than that of the
interface and the cell width, plus a distance of this neck from the interface of >1.3 µm.
When such scorable lamella was formed we measured the ”lamellal length” as the distance
between interface and neck and the “cell length” as the distance between the interface and
the posterior end of the T cell along the T cell midline. If the T cell was bent this line could
have inflection points. The measurements are graphically illustrated in Supplementary
Figure S5B. The “T cell shape factor” is calculated by dividing the lamellal length by the
interface diameter.
3. Results
3.1. Tg4 T Cells as a Model to Investigate Signaling in T Cells with Regulatory Capability
Immune regulation by T cells is critical in tolerance and autoimmune disease. There-
fore, we investigated signaling in T cells upon induction of regulatory function using the
Tg4 mouse model of multiple sclerosis. Tg4 CD4+ T cells [33] recognize the acetylated
N-terminal peptide of myelin basic protein Ac1-9[4K] and its high affinity MHC-binding
analogue Ac1-9[4Y] as presented by I-Au. Tg4 T cells differentiated into Th1 or Th17 cells
can mediate experimental autoimmune encephalitis in vivo [39]. To investigate signaling
upon Tg4 T cell effector function as reference data for the regulatory work, we generated
Tg4 effector T cells in vitro by priming naïve Tg4 lymphocytes with Ac1-9[4K] and subse-
quently expanding them in 50 U/mL IL-2 (“Teff pep”). The formation of supramolecular
signaling structures as determined by live cell imaging is a sensitive means to investigate
signaling. To visualize such structures, we retrovirally transduced in vitro primed Tg4 T
cells for the expression of GFP-tagged signaling intermediates and FACS-sorted GFP+ Tg4
Teff pep cells after five days of tissue culture as established [35] (Figure 1A).
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To investigate T cells with regulatory capability, we used three experimental strategies.
We generated inducible regulatory T cells by priming naïve Tg4 lymphocytes with Ac1-
9[4K] in the presence of 10 ng/mL TGFβ and 100 U/mL IL-2 (‘iTreg pep’) (Figure 1A) [40].
iTreg pep cell cultures were mostly >70% FoxP3+ (Figure 1B and Figure S1A) and not used
unless >75% FoxP3+. Retroviral transduction to express GFP-tagged signaling sensors
did not affect induction of FoxP3 (Supplementary Figure S1B). Consistent with regulatory
function the balance of cytokine secretion was shifted from IFNγ to IL-10 as compared to
Teff pep cells during iTreg pep induction (Figure 1C) and re-stimulation (Figure 1D). While
Teff pep cells consistently secreted more IFNγ than iTreg pep cells during a time course
of in vitro differentiation (p < 0.001), iTreg pep cells started to secret more IL-10 without
reaching statistical significance though at day 5, one day after a plateau of maximal FoxP3
expression was reached as described later.
Figure 1. Cont.
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Figure 1. Three experimental models of T cells with regulatory capability. (A) Schematic of Tg4 T cell culture to generate
Teff pep, iTreg pep, Ttol and Teff iPI4K cells; (B) Tg4 splenocytes were incubated with 10 µg/mL MBP Ac1-9[4K] peptide
for 5 days in the presence of 50 U/mL IL-2 or 10 ng/mL TGFβ and 100 U/mL IL-2 and stained for CD4 and FoxP3. Data
are expressed as % FoxP3+cells (n = 4–12 independent experiments). **** p < 0.0001; (C) Tg4 splenocytes were incubated
with 10 µg/mL MBP Ac1-9[4K] peptide for 6 days in the presence of 50 U/mL IL-2 or 10 ng/mL TGFβ plus 100 U/mL IL-2
and IFNγ and IL-10 amounts in tissue culture supernatants were determined by ELISA. Data are expressed as amount of
cytokine (n = 5 independent experiments). * p < 0.05, ** p < 0.01; (D) Tg4 eff pep or iTreg pep cells were re-activated with
PL8 APCs (10 µg/mL Ac1-9[4Y]) for 18 h and IL-10 amounts were determined by ELISA. Data are expressed as amount of
cytokine (n = 6 independent experiments); (E) Tg4 T cells were tolerized in vivo with a dose escalation of MBP Ac1-9[4K]
peptide in PBS or left untreated, incubated in vitro with 10 µg/mL MBP Ac1-9[4K] peptide for 5 days in the presence of
50 U/mL IL-2, retrovirally transduced to express GFP, re-activated with PMA and Ionomycin and stained for LAG-3, PD-1,
intracellular IL-10 and IFNγ. Data are expressed as % T cells positive for the indicated marker (n = 3). * p < 0.05, ** p < 0.01,
*** p < 0.001; (F) Naïve Tg4 T cells were labelled with the cell proliferation dye CellTrace Violet and incubated with irradiated
splenocytes and the indicated concentrations of MBP Ac1-9[4K] peptide for 4 days in the presence of 50 U/mL IL-2 with
the indicated concentration of UCB9608 or vehicle. Data are expressed as the average number of cell divisions (‘division
index’) at an MBP Ac1-9[4K] peptide concentration of 10 µg/mL. **** p < 0.0001; (G) Tg4 splenocytes were incubated with
the indicated concentrations of MBP Ac1-9[4K] peptide for 6 days in the presence of 50 U/mL IL-2 with 50 nM UCB9608 or
vehicle and stained for FoxP3. Data are expressed as MFI of FoxP3+ (n = 3). ** p < 0.01, **** p < 0.0001.
We generated FoxP3– Tg4 T cells with regulatory capability in vivo using an es-
tablished dose escalation protocol of repeated injection of mice with Ac1-9[4Y] under
non-immunogenic conditions [11]. We in vitro expanded and retrovirally transduced such
cells as done in the generation of Teff pep cells to generate tolerized Tg4 T cells (‘Ttol’)
(Figure 1A). Consistent with preservation of a regulatory phenotype upon in vitro tissue
culture, IL-10 expression was elevated in Ttol but not expression of IFNγ, again indepen-
dent of retroviral transduction (Figure 1E and Figure S1C). Expression of the inhibitory
receptors Lag3 and Pd-1 was elevated (Figure 1E).
Finally, in contrast to the induction of regulatory capacity over days in the iTreg pep
and Ttol cells, we acutely treated Tg4 Teff pep cells with 100 nM of the phosphatidylinositol
4-kinase IIIβ inhibitor UCB9608 (‘Teff iPI4K’). Treatment of mice with UCB9608 mediates
tolerance in heart transplantation [13]. UCB9608 inhibited the proliferation of Teff cells, i.e.,
induced anergy (Figure 1F and Figure S1D), and enhanced FoxP3 induction in the genera-
tion of iTregs (Figure 1G) at concentrations above 50 ng/mL (Supplementary Figure S1E).
In vivo UCB9608 reduced T cell numbers, yet the fraction of T cells expressing FoxP3,
the inhibitory receptors Tigit and Tim3 and IL-10 was increased in the remaining cells
as to be described in a future manuscript. Treatment with UCB9608 thus promoted a
regulatory phenotype.
This Tg4 experimental system allows an effective comparative investigation of signal-
ing in T cells with regulatory capability. Teff, iTreg, Ttol and Teff iPI4K cells all express the
same Tg4 TCR. By activating them with the same PL8 B cell lymphoma APCs incubated
with the same amount (10 µg/mL) of the same Ac1-9[4Y] agonist peptide all T cells receive
an identical TCR stimulus. Signaling differences could therefore be attributed to their
divergent differentiation state.
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3.2. LAT Accumulation at the Center of the T Cell APC Interface Was More Rapidly Terminated in
T Cells with a Regulatory Phenotype
Accumulation of LAT at the center of the T cell APC interface in a cluster of supramolec-
ular signaling complexes within the first two minutes of T cell activation promotes efficient
T cell activation [15,21]. LAT accumulation in a large invagination at the interface cen-
ter during the same time, however, is thought to initiate the termination of signaling
activity [22]. Distinguishing these opposing signaling events, the cluster of supramolec-
ular signaling complexes remains at the T cell APC interface while the invagination
reaches µm deep into the T cells. We imaged LAT accumulation in Tg4 T cells (Figure 2A,
Supplementary Video S1). LAT accumulated effectively at the interface center in the activa-
tion of Teff pep cells (Figure 2B, Figures S2A and S3A) reaching 60 ± 7% of cell couples with
interface accumulation in any pattern at 20s after the formation of a tight cell couple with
42 ± 7% at the interface center and 13 ± 5% in the invagination. Central LAT accumulation
varied in Tg4 T cells with a regulatory phenotype. It was almost completely lost in iTreg
pep cells, not exceeding 9% of cell couples with central accumulation at any time, partially
lost in Ttol cells, briefly peaking at 25 ± 6% of cell couples with central accumulation at the
time of tight cell coupling, and less well sustained in Teff iPI4K cells, dropping to less than
10% of cell couples with central accumulation at 60 s after tight cell coupling (Figure 2B,C
and Supplementary Videos S2–S4). However, the balance of LAT accumulation between
the central and invagination patterns was consistently shifted towards the invagination
(Figure 2D). In Teff pep cells central accumulation was more prominent than accumulation
in the invagination across all time points within the first two minutes of tight cell coupling,
the peak of LAT interface accumulation. In contrast, invagination accumulation was more
prominent from 20 s to 2 min for all three Tg4 T cell types with regulatory capability. A
rapid transition into the invagination, a likely degradative signaling structure, is indicative
of ill sustained LAT accumulation in a cluster of supramolecular signaling complexes at
the interface center.
Figure 2. Cont.
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Figure 2. LAT association with the cSMAC is terminated more rapidly in T cells with regulatory capability. Tg4 T cells
as indicated transduced to express LAT-GFP were activated with PL8 APCs (10 µg/mL Ac1-9[4Y]). (A) Representative
LAT-GFP imaging data. Differential interference contrast (DIC) images are shown in the top row, with top-down, maximum
projections of 3-dimensional LAT-GFP fluorescence data in the bottom row. LAT-GFP fluorescence intensities are displayed
in a rainbow-like false-color scale (increasing from blue to red). The scale bar corresponds to 5 µm. Corresponding videos
are available as Videos S1–S4. (B,C) Data are expressed as the percentage of cell couples with LAT-GFP accumulation in the
indicated patterns (Supplementary Figure S2A) relative to tight cell couple formation. Number of cell couples analyzed are
n = 49, 57, 72, 23 for Teff pep, Ttol, iTreg pep, Teff 9608 cells, respectively, from 2–5 independent experiments. Statistical
significance of differences between conditions is given in Table S1; (B) all patterns for each cell type separately; C only
central accumulation in direct comparison between the cell types; (D) The same data are expressed as the log2 of the ratio of
percent Tg4 T cells with accumulation in the central over the invagination pattern relative to tight cell couple formation.
Values above 0 indicate preferential central accumulation, below 0 preferential accumulation in the invagination. Data
points are slightly nudged to increase legibility. ** p < 0.01, **** p < 0.0001 vs. Teff pep.
iTregs are commonly generated by priming purified CD4+ T cells with agonist anti-
CD3 plus anti-CD28 in the presence of TGFβ and high concentrations of IL-2. As this
method is favored in clinical therapy settings, it is useful to also understand the function
and phenotype of antibody-stimulated iTreg. LAT interface accumulation during the first
two minutes of cell coupling, the time of maximal central LAT accumulation, in such
antibody-induced iTreg (“iTreg ab”) was comparable to that in iTreg differentiated by
stimulation with APC and agonist peptide (Supplementary Figure S2B–E). Sustained LAT
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accumulation in any pattern was more prominent in antibody as compared to peptide-
primed Teff and iTreg cells, as not further pursued here. The pattern-based image analysis
predominantly employed here is particularly powerful in distinguishing spatially similar
signaling distributions such as central accumulation versus invagination versus accumu-
lation in vesicles as commonly seen for LAT. A recently developed computational image
analysis routine [37,38] provides superior quantitation of the intensity of signaling accu-
mulations at the expense of diminished spatial resolution. Using this computational image
analysis routine, we found diminished LAT accumulation at the interface and its center in
iTreg pep as compared to Teff pep cells (Supplementary Figure S3B–D), thus corroborating
the pattern-based analysis. Together the LAT data establish that acquisition of a regulatory
phenotype consistently leads to the accelerated termination of LAT accumulation at the
interface center, suggesting more transient and limited signaling activity.
3.3. cSMAC Formation Was Diminished upon Induction of a Regulatory Phenotype
LAT accumulation at the interface center is part of the formation of the central
supramolecular activation cluster (cSMAC) [15]. In particular within the first two minutes
of T cell activation a large number of proximal T cell signaling events associate with the
cSMAC as required for efficient T cell activation [15]. To provide some insight into wider
defects in cSMAC formation, we investigated interface accumulation of two signaling
intermediates in some of the three models of Tg4 T cells with regulatory capacity. A key
proximal signaling event in T cell activation is the generation of diacylglycerol (DAG).
In Ttol cells interface accumulation of DAG as measured with a tandem C1 domain-GFP
sensor was substantially diminished (Figure 3A, Supplementary Video S5). In comparison
to Teff pep cells, DAG interface accumulation in Tg4 Ttol cells was reduced more rapidly
after similar initial accumulation at the time of tight cell couple formation, leading to
significantly (p < 0.05) reduced interface accumulation from 40 s to 180 s after tight cell
coupling. As DAG is rapidly diffusible diminished DAG accumulation was extended
across the entire interface.
Effective early cSMAC formation promotes subsequent clustering of the TCR at the
interface center [21]. Consistent with inefficient cSMAC formation, central TCR accu-
mulation five to seven minutes after tight cell coupling was substantially reduced in
Ttol and iTreg pep (Figure 3B, Supplementary Video S6) as confirmed in iTreg ab cells
(Supplementary Figure S4). While central TCRζ-GFP accumulation reached 25 ± 7%
of cell couples during that time in Teff pep cells it stayed below 5% and 10% in Ttol
and iTreg pep cells, respectively. Together (Figure 4) these data suggest that overall cS-
MAC formation and associated signaling activity were diminished in Tg4 T cells with
regulatory capacity.
As further discussed below, the Tg4 TCR is self-reactive. Central accumulation of the
TCR has been shown to be diminished in the activation of self-reactive CD4+ T cells [31]. It
is, therefore, of interest that central accumulation of all proteins investigated here in Tg4
Teff cells is consistently less extensive than that seen in the activation of foreign-reactive
5C.C7 and DO11.10 T cells by B cell lymphoma APCs and a high concentration of agonist
peptide, comparable to the activation conditions used here [15,41].
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Figure 3. cSMAC formation was diminished but not abolished upon induction of a regulatory phenotype. (A) Tg4 T cells as
indicated transduced to express Tandem C1-GFP as indicated were activated with PL8 APCs (10 µg/mL Ac1-9[4Y]). On the
left, representative tandem C1-GFP imaging data as in Figure 2A. A corresponding video is available as Video S5. On the
right, data are expressed as the percentage of cell couples with DAG accumulation measured with tandem C1-GFP in the
indicated patterns (Supplementary Figure S2A) relative to tight cell couple formation. Number of cell couples analyzed are
n = 56, 45 for Teff pep and Ttol cells, respectively, from 1 independent experiment each. Statistical significance of differences
between conditions is given in Table S3. (B) Tg4 T cells as indicated transduced to express TCRζ-GFP were activated with
PL8 APCs (10 µg/mL Ac1-9[4Y]). On the top left, representative TCRζ-GFP imaging data as in Figure 2A. A corresponding
video is available as Video S6. Data are expressed as the percentage of cell couples with TCRζ-GFP accumulation in the
indicated patterns (Supplementary Figure S2A) relative to tight cell couple formation. Number of cell couples analyzed are
n = 52, 48, 66 for Teff pep, Ttol, iTreg pep cells, respectively, from 3–5 independent experiments. Statistical significance of
differences between conditions is given in Table S3.
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Figure 4. Summary of central accumulation phenotypes. Changes in accumulation phenotypes of the different Tg4 cell
types with regulatory capability in comparison to Teff cells are summarized across all experiments with a focus on central
accumulation of the manuscript.
3.4. Actin-Driven Formation of a Polarized Cell Couple Was Impaired upon Induction of a
Regulatory Phenotype
Efficient early cSMAC formation requires rapid F-actin turnover [37]. One indicator
of efficient F-actin turnover is the rapid recruitment of F-actin to the T cell/APC inter-
face upon cell coupling. Such recruitment was delayed in iTreg pep, Ttol and Teff iPI4K
cells (Figure 5A–C, Supplementary Video S7). While in Teff pep cells interface F-tractin-
GFP [16] accumulation in any pattern reached 86 ± 4% already at the time of tight cell cou-
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pling, such accumulation did not exceed 85% until 60 s, 180 s, or ever in Ttol, Teff iPI4K or
iTreg pep cells, respectively, as corroborated in iTreg ab cells (Supplementary Figure S5A).
Early F-actin dynamics are required to first extend and then rapidly shorten initial often-
long cell-wide lamellal sheets that the T cell uses to make contact with the APC. In com-
parison to Teff pep cells, iTreg pep cells displayed an increased frequency of distinct
lamellae within the first minute of cell coupling with increased length relative to the
interface diameter (Supplementary Figure S5B–D), indicative of impaired lamellal short-
ening. In contrast, Ttol and Teff iPI4K cells displayed shorter and less frequent lamellae
(Supplementary Figure S5B–D), consistent with impaired lamellal extension. Both pheno-
types, impaired extension and shortening of early lamellae are consistent with slowed
F-actin turnover. Slowed early F-actin dynamics are in turn consistent with the less efficient
formation and/or more rapid termination of cSMAC signaling.
Figure 5. Cont.
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Figure 5. Actin-driven formation of a polarized cell couple is impaired upon induction of a regulatory phenotype. Tg4 T cells
as indicated transduced to express F-tractin-GFP were activated with PL8 APCs (10 µg/mL Ac1-9[4Y]). (A) Representative
F-tractin-GFP imaging data as in Figure 2A. A corresponding video is available as Video S7. (B,C) Data are expressed as the
percentage of cell couples with F-tractin-GFP accumulation in the indicated patterns (Supplementary Figure S2A) relative to
tight cell couple formation. Number of cell couples analyzed are n = 76, 38, 49, 38 for Teff pep, Ttol, iTreg pep, Teff 9608
cells, respectively, from 2–6 independent experiments. Statistical significance of differences between conditions is given in
Table S5; (B) All patterns for each cell type separately; (C) accumulation in any pattern (left) and in the diffuse and lamellal
pattern (right) in direct comparison between the cell types. (D) The same data are expressed as the percentage of Tg4 T
cells with off-interface lamellae, cumulative up to the indicated time relative to tight cell coupling. Some data points are
slightly nudged to increase legibility. (E) Changes in accumulation phenotypes of the different Tg4 cell types with regulatory
capability in comparison to Teff cells are summarized across all experiments with a cytoskeletal focus of the manuscript.
At later time points the formation of smaller off-interface lamellae is an indication
of impaired cell couple maintenance [38,42]. The frequency of cell couples with such
off-interface lamellae within the first 7 min after tight cell coupling was increased from
58 ± 4% in Teff pep cells to 70 ± 5%, 73 ± 2% and 88 ± 2% in Teff iPI4K, Ttol, and iTreg
pep cells (Figure 5D), respectively. Again, the iTreg pep cells displayed the most severe
defect. Such later F-actin defects are indicative of consistently impaired F-actin dynamics
upon induction of a regulatory phenotype.
F-actin dynamics not only drive cell couple polarization, they can also directly sup-
port signaling through the formation of an F-actin sheet with embedded smaller signaling
complexes, in particular within the first two minutes of cell coupling [18]. We observed
a shift in the pattern of F-actin interface accumulation from some lamellal/diffuse accu-
mulation in Teff pep cells to almost exclusively peripheral patterning in both Ttol and
Teff iPI4K cells (Figure 5B). The combined diffuse and lamellal accumulation of F-tractin
in Teff pep cells stayed at or above 40% of cell couples during the entire first minute of
tight cell coupling, indicative of substantial formation of a lamellal F-actin network. It
did not exceed 10% in Ttol and Teff iPI4K cells and stayed around 20% in iTreg pep cells
during the same period of time (Figure 5C). While details varied, F-actin dynamics in rapid
F-actin interface recruitment, lamellal extension and retraction, off-interface lamellae and
the formation of a signaling-sustaining F-actin sheet were consistently impaired in T cells
with regulatory capability.
In summary of the imaging experiments to investigate the formation of supramolecular
structures in Tg4 T cell activation, the induction of a regulatory phenotype consistently led
to less efficient T cell polarization, in early and sustained F-actin dynamics as associated
with diminished formation of supramolecular signaling structures, most prominently the
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cSMAC but also the F-actin-based lamellae (Figure 4; Figure 5E). The extensive scope
of these defects is indicative of broadly attenuated signaling activity upon induction of
regulatory capability.
3.5. cSMAC Formation Could Be Partially Restored with Synthetic Approaches in Tg4 iTreg
Pep Cells
The cSMAC consists of multiple supramolecular signaling complexes [15]. Their
formation is diminished upon attenuation of T cell stimulation [15]. Supramolecular sig-
naling complexes require a network of multi-valent interactions for their formation [43,44].
Therefore, diminished formation is likely caused by a reduced valence in the associated
signaling intermediates, e.g., through reduced tyrosine phosphorylation that is required
for many phospho-tyrosine SH2 domain interactions in proximal T cell signaling. This
reduction in valence in cSMAC formation can be overcome by adding protein interaction
domains to LAT [15]. To investigate whether the impaired cSMAC formation upon in-
duction of a regulatory phenotype is consistent with this model of cSMAC function, we
expressed two LAT variants with increased valence in Tg4 iTreg pep cells, LAT fused to
the V3 domain of PKCθ (‘LAT V3’) and LAT fused to the Vav1 SH3-SH2-SH3 domain
module (‘LAT Vav’) [15]. The V3 domain of PKCθ and the Vav1 SH3-SH2-SH3 domain
module drive sustained central accumulation and central accumulation during the first
minute of cell coupling, respectively. Overall iTreg pep cell LAT interface accumulation
was greatly increased upon expression of LAT V3 and LAT Vav reaching or even exceed-
ing levels seen in Teff pep cells (Figure 6A,B, Supplementary Video S8) as corroborated
in iTreg ab cells and by computational image analysis (Supplementary Figure S6A,B).
While LAT accumulation in any interface pattern did not exceed 30% of cell couples
in iTreg cells expressing LAT-GFP (Figure 2B), it reached 80 ± 5% and 63 ± 7% upon
expression of LAT V3-GFP and LAT Vav-GFP, respectively (Figure 6B). However, the
LAT accumulation at the interface center was only partially restored (Figure 6C), even
though the balance of central LAT accumulation to that in the invagination reached the
same level as seen in Teff pep cells (Figure 6D). While accumulation in the invagination
was consistently more prominent than that in the cSMAC in iTreg pep T cells express-
ing LAT-GFP throughout the first minute of cell coupling, the opposite occurred for
iTreg pep cells expressing LAT V3-GFP or LAT Vav-GFP, comparable to Teff pep cells
(Figure 6D). Consistent with a close mutual connection between early cSMAC formation
and F-actin dynamics, the ability of iTreg pep cells to shorten the initial lamellal sheet used
to make contact with APCs was partially restored upon expression of LAT V3 and LAT Vav
(Supplementary Figure S6C).
Figure 6. Cont.
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Figure 6. cSMAC formation can be partially restored with synthetic approaches in Tg4 iTreg pep cells. (A–D) Tg4 T cells as
indicated transduced to express LAT-GFP, LAT V3-GFP or LAT-Vav were activated with PL8 APCs (10 µg/mL Ac1-9[4Y]).
(A) Representative LAT V3-GFP and LAT-Vav imaging data as in Figure 2A. A video corresponding to the LAT-V3-GFP data is
available as Video S8. (B,C) Data are expressed as the percentage of cell couples with LAT-GFP, LAT-V3-GFP or LAT Vav-GFP
accumulation as noted in the indicated patterns (Supplementary Figure S2A) relative to tight cell couple formation. Number of
cell couples analyzed are n = 57, 43 for iTreg pep cells expressing LAT V3-GFP and LAT Vav-GFP, respectively, from 4 and
2 independent experiments. LAT-GFP data are from Figure 2B. Statistical significance of differences between conditions is given
in Table S8; (B) all patterns for each cell type and LAT construct separately; (C) only central accumulation in direct comparison
between the cell types and LAT constructs; (D) The same data are expressed as the log2 of the ratio of percent Tg4 T cells
with accumulation in the central over the invagination pattern relative to tight cell couple formation. LAT-GFP data are from
Figure 2D. Data points are slightly nudged to increase legibility. E Tg4 iTreg pep cells transduced to express LAT-GFP, LAT
V3-GFP or LAT-Vav were activated with PL8 APCs (10 µg/mL Ac1-9[4Y]) for 18 h. Data are expressed as amount of IFNγ and
IL-10 in tissue culture supernatants from 3 independent experiments, each, and also as the log2 of the ratio of IFNγ and IL-10 in
iTreg pep cells expressing LAT V3-GFP or LAT Vav-GFP relative to those expressing LAT-GFP.
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In the work on costimulation blockade in 5C.C7 Teff cells, restoration of diminished
IL-2 generation upon costimulation blockade as a key T cell effector function required
rebuilding the cSMAC to levels very similar to those in T cell receiving a full stimulus,
not more, not less [15]. To investigate whether such restoration equally applies to Tg4
T cells, we determined cytokine secretion in iTreg cells expressing LAT-V3 or LAT-Vav.
Upon expression of LAT V3-GFP secretion of IL-10 and IFNγ was diminished (Figure 6E),
consistent with reduced IL-2 generation in 5C.C7 CD4+ Teff cells upon similarly excessive
reconstitution of LAT clustering with LAT V3 upon costimulation blockade [15]. Upon
expression of LAT Vav-GFP, however, we observed a trend towards more efficient IL-10
secretion, with no effect on IFNγ (Figure 6E), a trend comparable to restoration of IL-2
generation in 5C.C7 T cells expressing LAT-Vav upon costimulation blockade. Consistent
with such work, restoration of LAT clustering in Tg4 iTreg cells with LAT Vav more
closely resembled Teff pep cells than restoration with LAT V3. However, in contrast to
the 5C.C7 T cell work, such restoration still left substantial differences, i.e., excessive LAT
accumulation in any pattern and incomplete restoration of central accumulation. This
only partial restoration may explain the more limited functional effect in Tg4 as compared
to 5C.C7 T cells. Nevertheless, together (Figure 4) these data support the notion that
valence-driven early cSMAC formation is an amplifier of T cell effector function also in
Tg4 T cells, including a reduction upon induction of a regulatory phenotype.
3.6. Pd-1 and Ctla-4 Impaired cSMAC Formation upon Induction of a Regulatory Phenotype
The identification of molecular regulators of diminished proximal signaling upon
induction of regulatory capability is of interest. Regulatory T cells, including Tg4 iTreg,
Ttol and Tg4 T cells from mice treated with UCB9608, displayed increased expression of
inhibitory receptors (Figure 1E) [7,11,23,24]. We, therefore, determined the role of two of
the most prominent inhibitory receptors, Pd-1 and Ctla-4, on the signaling of iTreg pep cells
using blocking antibodies. Blockade of iTreg pep cells with α-Pd-1 plus α-Ctla-4 partially
restored early central LAT accumulation and partially overcame the rapid movement of
LAT into the invagination (Figure 7A–C, Supplementary Video S9). While accumulation in
the invagination was consistently more prominent than that in the cSMAC in iTreg pep
T cells throughout the first minute of cell coupling, the opposite occurred upon blockade of
Pd-1 and Ctla-4, more comparable to Teff pep cells (Figure 7C). Partial restoration of central
LAT accumulation was confirmed in iTreg ab cells with a slightly more pronounced effect
of α-Ctla-4 as opposed to α-Pd-1 and without substantial synergy between the treatments
(Supplementary Figure S7A). Computational analysis confirmed partial reconstitution of
overall LAT interface accumulation (Supplementary Figure S7B).
Consistent with a role of early cSMAC formation in generating signals necessary for
later TCR accumulation, TCR accumulation at the interface center was restored in iTreg pep
cells upon blockade of Pd-1 and Ctla-4 (Figure 7D, Supplementary Figure S7C). Central
accumulation of TCRζ-GFP reached 49 ± 8% of cell couples 7 min after cell coupling in
iTreg pep cells upon blockade of Pd-1 and Ctla-4, significantly (p < 0.001) exceeding such
accumulation in control treated iTreg pep cells (5 ± 3%) and more comparable to Teff pep
cells (25 ± 7%). Again, linking the cSMAC to F-actin dynamics, the ability of iTreg pep cells
to shorten the initial lamellal sheet used to make contact with APCs was partially restored
upon blockade of Pd-1 and Ctla-4 (Supplementary Figure S8A) with little effect on overall
F-actin accumulation (Supplementary Figure S8B). These data establish the inhibitory
receptors Ctla-4 and Pd-1 as consistent regulators of the spatiotemporal organization of T
cell signaling, in cSMAC formation, subsequent TCR clustering and F-actin dynamics. The
effect of the antibodies is likely caused by the direct blockade of ligand binding of Ctla-4
and Pd-1 by the antibodies rather than by steric interference with synapse organization by
the antibody/inhibitory receptor complexes, as dextran with a diameter of 13 nm, larger
than an antibody, can readily move through the interface between a Jurkat T cell with a
Raji APC [45].
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As a process on a different timescale than the re-activation of iTreg cells investigated
in our imaging experiments, blocking Pd-1 and Ctla-4 also interfered with the induction
of iTreg cells. Blockade of Pd-1 and Ctla-4 led to a substantial reduction of the percentage
of FoxP3+ cells upon differentiation of Tg4 splenocytes in the presence of TGFβ and IL-2
(Supplementary Figure S8C,D) from 66 ± 5% of Tg4 T cells with expression of FoxP3 at day
6 to 45 ± 5% with synergy between α-Pd-1 and α-Ctla-4 (Supplementary Figure S8C). This
was accompanied by significantly (p < 0.01) enhanced IL-10 secretion during the in vitro T
cell differentiation in the presence of TGFβ and IL-2 (Supplementary Figure S8E). While
not further pursued here, the attenuated signaling in T cells with regulatory capability may
thus extend to their induction.
Figure 7. Cont.
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Figure 7. Pd-1 and Ctla-4 impair cSMAC formation upon induction of a regulatory phenotype. (A–C) Tg4 T cells as
indicated transduced to express LAT-GFP were activated with PL8 APCs (10 µg/mL Ac1-9[4Y]). A Representative LAT-GFP
imaging data upon treatment with 10 µg/mL α-Pd-1 plus α-Ctla-4 as in Figure 2A. A corresponding video is available as
Video S9. (B) The data are expressed as the percentage of cell couples with LAT-GFP accumulation in the indicated patterns
(Supplementary Figure S2A) relative to tight cell couple formation. Number of cell couples analyzed are n = 51 for iTreg
pep cells in the presence of 10 µg/mL α-Pd-1 plus α-Ctla-4 from 3 independent experiments. Statistical significance of
differences between conditions is given in Table S10. Teff pep and iTreg pep data are from Figure 2B. The panel in the
third row at the left is a direct comparison of central accumulation under the three experimental conditions. (C) The same
data are expressed as the log2 of the ratio of percent Tg4 T cells with accumulation in the central over the invagination
pattern relative to tight cell couple formation. Teff pep and iTreg pep data are from Figure 2D. Data points are slightly
nudged to increase legibility. (D) Tg4 T cells as indicated transduced to express TCRζ-GFP were activated with PL8 APCs
(10 µg/mL Ac1-9[4Y]). The graphs display the percentage of cell couples with TCRζ-GFP accumulation in the indicated
patterns (Supplementary Figure S2A) relative to tight cell couple. Number of cell couples analyzed are n = 45 for iTreg
pep cells in the presence of 10 µg/mL α-Pd-1 plus α-Ctla-4 from 2 independent experiments. Statistical significance of
differences between conditions is given in Table S10. Teff pep and iTreg pep data are from Figure 3B. The panel in the last
row on the right is a direct comparison of central accumulation under the three experimental conditions.
4. Discussion
Here we have investigated supramolecular signaling structures in the activation of T
cells with a regulatory capability. By using the Tg4 TCR transgenic system [33] to generate
effector T cells, iTregs, in vivo tolerized T cells and T cells acutely tolerized by treatment
with UCB9608 we can activate the T cells with the same PL8 B cell lymphoma APCs
presenting the same MBP Ac1-9[4Y] agonist peptide at the same concentration of 10 µg/mL.
Resulting changes in T cell signaling are then not governed by different modalities of TCR
engagement but are the consequence of different functional states of the T cells. We thus
found that proximal signaling as determined through the formation of supramolecular
signaling structures was consistently attenuated in T cells with regulatory capability. In
comparing Tg4 data to those generated using other primary TCR transgenic T cells, one
needs to consider that the Tg4 TCR is self-reactive. Self-reactive T cells show diminished
clustering of their TCR at the interface center [31]. Comparing the Tg4 Teff pep data to
data from the activation of T cells expressing the foreign-reactive TCRs 5C.C7 or DO11.10
with B cell lymphoma APCs and a high concentration of agonist peptide [15,18,21,46],
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comparable to the T cell activation conditions used here, central accumulation of LAT,
DAG and TCRζ was diminished moderately in the Tg4 Teff pep cells. These data thus
confirm the prior work and extend it to other signaling intermediates. Nevertheless, faster
termination of central signaling accumulation was a principal signaling defect in Tg4 T cells
with regulatory capability established here. In 5C.C7 T cells central signaling accumulation
is indicative of the formation of a cluster of membrane-anchored supramolecular protein
complexes [15]. Central signaling accumulation in Tg4 T cells also most likely represents
the formation of supramolecular protein complexes: Such formation critically depends on
the valence of complex components [44,47]. Accordingly, expression of LAT variants with
addition of protein interactions domains to increase LAT valence enhanced central signaling
localization in Tg4 iTreg pep, similar to 5C.C7 T cells upon costimulation blockade [15].
Our findings raise a number of questions.
What are the molecular regulators of diminished central signaling? Tg4 iTreg pep and
Ttol cells express increased amounts of inhibitory receptors. Blocking two of them, CTLA-4
and PD-1, at least partially restored central signaling localization in Tg4 iTreg pep cells
(Figure 7) implying inhibitory receptors as regulators of central signaling. CTLA-4 and PD-1
are well placed to do so through their connections to costimulatory signaling. CD28 engage-
ment accelerates F-actin turnover and thus contributes to central LAT accumulation [37].
CTLA-4 directly competes with CD28 for CD80/CD86 ligand engagement [9,48–50]. PD-1
inhibits the activity of the critical costimulatory signaling intermediate Akt [51]. The delay
in the formation of a peripheral F-actin ring in T cells with a regulatory capability (Figure 5)
is consistent with a costimulation-driven actin-dependent regulation of central signaling
localization in Tg4 T cells. As an alternate costimulation-linked signaling event, accumula-
tion of the E3 ubiquitin ligase Cbl-b at interface between T cells and an activating cover slip
as an APC substitute is enhanced in in vivo tolerized Tg4 T cells [32], as also seen in the
activation of anergic CD4+ T cells [29]. Beyond costimulation, the suggested recruitment of
the tyrosine phosphatase SHP-2 to PD-1 [52] could directly interfere with tyrosine phos-
phorylation in TCR signal transduction, consistent with diminished recruitment of ZAP-70
to the interface between in vivo tolerized Tg4 T cells and APCs [32]. It remains unclear
whether acute induction of regulatory capability through treatment with UCB9608 is re-
lated to inhibitory receptors. Given that CTLA-4 is largely stored in vesicles [53], inhibition
of phosphatidylinositol 4-kinase IIIβ could affect insertion of CTLA-4 into or removal from
the plasma membrane during T cell activation. While suppressed costimulatory signaling
in T cells with regulatory capability is consistent with much of our data, future work will
have to conclusively resolve the mechanism of diminished central signaling.
What is the time scale of the induction of signaling changes that are associated with a
regulatory state? Cell signaling can be regulated on the time scale of seconds to minutes,
for example through post-translational modifications. Cell signaling can be regulated
on the time scale of days, for example through changes in the expression of signaling
intermediates. The times scales of the induction of signaling changes underpinning a
regulatory state are of interest as they are likely linked to how quickly regulatory states can
be reversed again. Differentiation of T cells into Tregs and in vivo tolerization of Tg4 T cells
leads to transcriptional changes as controlled by epigenetic modifications [32,54,55]. At
least some of the signaling changes observed here thus are likely induced and maintained
on the time scale of days. Nevertheless, acute treatment of Tg4 Teff pep cells with UCB9608
induced regulatory signaling features on the time scale of minutes and bypassing proximal
signaling in in vivo tolerized Tg4 T cells with phorbol ester and a calcium ionophore can
reverse consequences of transcriptional changes [32]. We, therefore, expect that long and
short-term adaptations synergize in the induction of regulatory states. As central signaling
was more extensively diminished in Tg4 iTreg and Ttol cells than in Teff iPI4K cells, we
also expect that long-term adaptation leads to a more profound and, therefore, possibly
more stable establishment of a regulatory state.
What is the functional significance of diminished central signaling in T cells with
regulatory capability? Diminished central signaling could be critical in diverting T cell
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activation from effector to regulatory responses. Alternatively, it could simply attenuate
all aspects of T cell activation. Enhanced secretion of IFNγ and IL-10 upon restoration
of central signaling organization in Tg4 iTreg pep cells by expression of LAT variants
with additional protein interaction motifs (Figure 6) or during T cell differentiation by
blocking inhibitory receptors (Supplementary Figure S8C–E) suggest a general attenuation
of T cell effector function in T cells with regulatory capability. What purpose could that
serve? Regulatory T cells are not limited to suppressive functionality. They can revert to
the execution of effector functions of conventional T cells, such as the secretion of pro-
inflammatory cytokines [56]. Signaling may contribute to this balance. Some effector
functions in regulatory T cells don’t require strong T cell signal transduction, such as
high expression of CD25 to allow effective competition for IL-2 [57,58] or high CTLA-4
expression to compete with costimulation [9,59]. We speculate that a general attenuation of
T cell signaling in T cells with regulatory capability serves to shift the balance from effector
functions that are most prominent upon strong T cell signaling to regulatory function that
is independent of strong signaling.
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